Archer Materials advances biochip toward clinical trial readiness
Archer Materials (ASX:AXE) has transitioned its biochip from a lab-based alpha prototype to an integrated, clinical-grade sensing system.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Archer Materials (ASX:AXE) has transitioned its biochip from a lab-based alpha prototype to an integrated, clinical-grade sensing system.
Crypto data company Dune has cut 25% of its workforce as part of a restructuring designed to sharpen focus on its core blockchain data products and institutional services.
Auckland Airport’s (ASX:AIA) latest traffic report reveals a complex shift in New Zealand’s aviation landscape.
Dogecoin recorded increased futures trading activity as trading volumes in Bitcoin, Ethereum and XRP weakened.
David Schwartz warned XRP Ledger users about a growing wave of fake airdrop and giveaway scams targeting the XRP community across social media platforms.
The US Senate Banking Committee voted to advance the Digital Asset Market Clarity Act (CLARITY), moving the long-awaited cryptocurrency market structure legislation one step closer to a full Senate vote.
Super League Enterprise (NASDAQ:SLE) reported growing top-line revenue and expanding gross profit margins for the first quarter of 2026, indicating that its recent corporate restructuring is beginning to translate into stronger financial efficiency.
Sensei Biotherapeutics (NASDAQ:SNSE) reported a significantly wider net loss for the first quarter of 2026, primarily driven by massive, one-time accounting charges stemming from its transformational acquisition of Faeth Therapeutics Inc. earlier in the year.
Perth-based Alkane Resources (ASX:ALK) announced its financial results for the third quarter ended March 31.
Meridian Energy (ASX:MEZ) secured resource consent for the Bunnythorpe Solar Farm.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy